Study guide
Delirium and dementia assessment
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Delirium and dementia assessment
Key Takeaways Explain This Topic AI
Delirium fluctuates and commonly impairs attention.
Treat underlying causes and provide supportive orientation and environmental care.
Do not diagnose dementia from a cognitive score alone.
Last updated: October 2026
Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Clinical psychiatry encompasses specialized populations that present unique diagnostic and therapeutic challenges across the human lifespan. In Australian healthcare settings, clinicians must adroitly distinguish between acute organic brain syndromes (delirium) and chronic neurodegenerative diseases (dementia) in elderly patients, identify and manage psychiatric emergencies across the perinatal period, and diagnose and treat neurodevelopmental and behavioural disorders in children and adolescents.
Delirium vs Dementia: Clinical Differentiation & Bedside Assessment
Delirium is an acute neurocognitive syndrome characterized by transient cognitive dysfunction, attentional deficits, and fluctuating consciousness provoked by an underlying medical illness, intoxication, or medication adverse effect. In contrast, dementia (Major Neurocognitive Disorder) represents a gradual, progressive decline in cognitive function that interferes with independent daily activities.
Clinical Subtypes of Delirium
Hyperactive Delirium : Characterized by psychomotor agitation, restlessness, combative behaviour, hypervigilance, and prominent visual hallucinations. Readily recognized by ward staff.
Hypoactive Delirium : Characterized by lethargy, reduced motor activity, drowsiness, psychomotor slowing, apathy, and poverty of speech. AMC High-Yield Pitfall : Hypoactive delirium is the most common subtype in elderly inpatients but is frequently missed or misdiagnosed as depression, fatigue, or worsening dementia, carrying higher mortality due to delayed investigation.
Mixed Delirium : Rapidly oscillates between hyperactive and hypoactive states, often worsening nocturnal confusion ("sundowning").
Validated Bedside Diagnostic Instruments
Confusion Assessment Method (CAM) : Delirium diagnosis requires both Feature 1 and Feature 2 , plus either Feature 3 or Feature 4 :
Acute Onset and Fluctuating Course (evidence of sudden change from baseline and fluctuating severity).
Inattention (difficulty focusing, easily distracted, unable to keep track of conversation).
Disorganized Thinking (incoherent, rambling, illogical narrative).
Altered Level of Consciousness (hyperalert, lethargic, stuporous).
4AT Scale : Rapid, 2-minute clinical tool used across Australian emergency and surgical wards: (1) Alertness, (2) AMT4 (age, date of birth, place, current year), (3) Attention (months of the year backwards), and (4) Acute change or fluctuating course. A score ≥ 4 \ge 4 ≥ 4 suggests delirium.
Etiological Workup: The "PINCHES ME" Mnemonic
Every case of delirium mandates a systematic search for underlying triggers:
P : Pain (uncontrolled surgical, visceral, or musculoskeletal pain).
I : Infection (urinary tract infection, pneumonia, cellulitis, sepsis, meningitis).
N : Nutrition & Dehydration (poor oral intake, severe volume depletion, malnutrition).
C : Constipation & Faecal Impaction.
H : Hydration & Electrolytes (hyponatraemia, hypercalcaemia, uremia, hepatic failure).
E : Endocrine (hypoglycaemia, severe hyperglycaemia, myxoedema coma, thyrotoxicosis).
S : Stroke & Cardiac (CVA, transient ischemic attack, silent myocardial infarction, heart failure).
M : Medications (anticholinergics, sedatives, opioids, corticosteroids, polypharmacy) or withdrawal.
E : Environmental change (ICU admission, sensory deprivation, absent sensory aids).
Management Principles of Delirium
Non-Pharmacological Measures (First-Line) : Frequent reorientation by nursing staff, visible clocks and calendars, re-fitting patient's spectacles and hearing aids, ensuring daytime natural lighting and dark quiet rooms at night, mobilizing early, and involving family members.
Pharmacological Restraint : Strictly reserved for severe hyperactive delirium where the patient poses imminent danger to self or staff (e.g., attempting to climb over bed rails with fractured hips, pulling out tracheostomies or central lines) and non-pharmacological de-escalation has failed. Low-dose haloperidol ( 0.25 − 0.5 mg 0.25-0.5\text{ mg} 0.25 − 0.5 mg oral/IM) or low-dose risperidone ( 0.25 mg 0.25\text{ mg} 0.25 mg ); avoid benzodiazepines unless delirium is caused by alcohol or sedative withdrawal.
Dementia Subtypes & Management Principles
Major Neurocognitive Disorder involves substantial cognitive decline across one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual-motor, or social cognition) that impairs functional independence.
1. Alzheimer's Disease (AD)
Most prevalent dementia subtype. Neurodegeneration begins in the entorhinal cortex and hippocampus, driven by amyloid plaques and neurofibrillary tangles, leading to severe cholinergic deficits.
Clinical Presentation : Insidious short-term episodic memory impairment (forgetting recent conversations, repeating questions, misplacing items), followed by dysphasia, dyspraxia, visuospatial disorientation, and executive impairment. Long-term semantic memories are preserved until late stages.
Pharmacotherapy :
Cholinesterase Inhibitors (AChEIs) : Donepezil , rivastigmine , and galantamine for mild-to-moderate AD. Common side effects: nausea, vomiting, diarrhoea, anorexia, vivid dreams, bradycardia, and syncope (contraindicated in severe sick sinus syndrome or high-grade AV block).
NMDA Receptor Antagonist : Memantine blocks pathologically elevated tonic levels of glutamate, preventing excitotoxic neuronal damage; used in moderate-to-severe AD either as monotherapy or combined with an AChEI.
2. Vascular Dementia (VaD)
Stepwise or abrupt deterioration associated with cerebrovascular insults. Patients exhibit early and prominent executive dysfunction (impaired abstract reasoning, poor planning, psychomotor slowing) out of proportion to episodic memory loss.
Physical examination demonstrates focal neurological signs (asymmetrical hyperreflexia, extensor plantars, pseudobulbar affect, gait disturbance).
Vascular cognitive impairment: Treat vascular risks. Antiplatelets or anticoagulants require a suitable vascular indication; the dementia label alone is not an indication. Assess cognition, function, mood, medicines and reversible contributors.
3. Dementia with Lewy Bodies (DLB)
Characterized by intracellular alpha-synuclein inclusions (Lewy bodies) in subcortical and neocortical neurons. Clinically defined by a core triad/tetrad:
Fluctuating Cognition : Pronounced variations in attention, alertness, and functional capacity occurring over hours to days.
Recurrent Vivid Visual Hallucinations : Typically well-formed, detailed figures of people, animals, or children, often non-distressing.
Spontaneous Parkinsonism : Rigidity, bradykinesia, and postural instability emerging concurrently with or within 12 months of cognitive decline (unlike Parkinson's Disease Dementia where motor symptoms precede cognitive decline by years).
REM Sleep Behaviour Disorder (RBD) : Loss of normal muscle atonia during REM sleep, leading to violent dream enactment.
CRITICAL AMC BLACK BOX PRECAUTION : Patients with DLB possess extreme, potentially fatal neuroleptic hypersensitivity . Exposure to first-generation antipsychotics (haloperidol) or standard-dose atypical antipsychotics can precipitate catastrophic irreversible parkinsonism, acute severe rigidity, profound sedation, autonomic collapse, or fatal Neuroleptic Malignant Syndrome. If psychosis requires treatment, cholinesterase inhibitors are first-line; if severe distress persists, very low-dose quetiapine or clozapine is used with extreme caution.
4. Frontotemporal Dementia (FTD)
Characterized by localized degeneration of the frontal and anterior temporal lobes, presenting at a younger age ( 50 − 65 years 50-65\text{ years} 50 − 65 years ). Subtypes include Behavioural Variant FTD (bvFTD) and Primary Progressive Aphasia (PPA).
Behavioural Variant FTD (bvFTD) : Early and profound personality change, social disinhibition (tactless remarks, inappropriate sexual behaviour, shoplifting), loss of empathy and emotional warmth, apathy, hyperorality (marked dietary changes, binging on sweets, smoking), and repetitive stereotypic motor behaviours. Remarkably, episodic memory and visuospatial orientation remain intact in early disease.
Primary references (checked 7 October 2026): RCH ADHD guidance .